Why I didn’t buy an #AppleWatch // @seemacnbc #Fitness #TechSexy #BlogChat 


Edit  After shopping the Apple Watch on apple.com, I quickly concluded 3 things: 1. A watch is a very personal accessory.  Let’s face it: As much as it tells time or monitors fitness data, it makes a statement about you. 2. I was unsure how the Apple Watch would look on my wrist. 3. I better visit the friendly team at the Apple Store, try one on, and learn more about it. On Saturday, April 18 I visited the Apple Store at Ridgedale mall in Minnetonka, MN, made an appointment to try one on, and went through a demo of … Continue reading Why I didn’t buy an #AppleWatch // @seemacnbc #Fitness #TechSexy #BlogChat 

#AlignedValue: “Talent alone doesn’t make a great team” // Do you agree? #Leadership #TalentManagement #HR #HCM


“Talent alone doesn’t make a great team.  You need faith in your colleagues and alignment behind a common goal.” – United States General (Ret.) Stanley McChrystal If talent isn’t enough, what else is needed? Fundamental Problem: The U.S. Military, composed of teams of highly talented service men and women, was failing to prevent terrorist attacks. In 2003, Gen. Stanley McChrystal took command of the United States’ Joint Special Operations Command (JSOC), an association of elite forces such as the Navy SEALS, Army Rangers, and Delta Force. His mission: to defeat al-Qaida in Iraq. JSOC had superior technology, skills, and resources. They were far better organized, … Continue reading #AlignedValue: “Talent alone doesn’t make a great team” // Do you agree? #Leadership #TalentManagement #HR #HCM

Billion Dollar #Biotech #VentureCapital Boom | MIT Technology Review


Venture Capitalists Love Biotech Right Now Scientific advances and new business models are spurring investor confidence in biomedical-related ventures. By Mike Orcutt on February 24, 2015 Why It Matters Developing innovative drugs, therapies, and devices is often extremely expensive. Venture capital investment in U.S. life sciences companies soared 29 percent in 2014 from the year before, reaching $8.6 billion, the highest level since 2007. And there is reason to think 2015 will also be a big year for a sector having its third boom of the last two decades.1 Biotech is the second biggest category for venture investment after software. … Continue reading Billion Dollar #Biotech #VentureCapital Boom | MIT Technology Review